Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Lobular histology and response to neoadjuvant chemotherapy in invasive breast cancer.

Lips EH, Mukhtar RA, Yau C, de Ronde JJ, Livasy C, Carey LA, Loo CE, Vrancken-Peeters MJ, Sonke GS, Berry DA, Van't Veer LJ, Esserman LJ, Wesseling J, Rodenhuis S, Shelley Hwang E; I-SPY TRIAL Investigators.

Breast Cancer Res Treat. 2012 Nov;136(1):35-43. doi: 10.1007/s10549-012-2233-z. Epub 2012 Sep 8.

PMID:
22961065
2.

Differences in Response and Surgical Management with Neoadjuvant Chemotherapy in Invasive Lobular Versus Ductal Breast Cancer.

Truin W, Vugts G, Roumen RM, Maaskant-Braat AJ, Nieuwenhuijzen GA, van der Heiden-van der Loo M, Tjan-Heijnen VC, Voogd AC.

Ann Surg Oncol. 2016 Jan;23(1):51-7. doi: 10.1245/s10434-015-4603-3. Epub 2015 May 16.

3.

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.

Cocquyt VF, Blondeel PN, Depypere HT, Praet MM, Schelfhout VR, Silva OE, Hurley J, Serreyn RF, Daems KK, Van Belle SJ.

Eur J Surg Oncol. 2003 May;29(4):361-7.

PMID:
12711290
4.

Clinical benefit from neoadjuvant chemotherapy in oestrogen receptor-positive invasive ductal and lobular carcinomas.

Delpech Y, Coutant C, Hsu L, Barranger E, Iwamoto T, Barcenas CH, Hortobagyi GN, Rouzier R, Esteva FJ, Pusztai L.

Br J Cancer. 2013 Feb 5;108(2):285-91. doi: 10.1038/bjc.2012.557. Epub 2013 Jan 8.

5.

Response to neoadjuvant chemotherapy in ductal compared to lobular carcinoma of the breast: a meta-analysis of published trials including 1,764 lobular breast cancer.

Petrelli F, Barni S.

Breast Cancer Res Treat. 2013 Nov;142(2):227-35. doi: 10.1007/s10549-013-2751-3. Epub 2013 Nov 1.

PMID:
24177758
6.

Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.

Truin W, Roumen RM, Siesling S, van der Heiden-van der Loo M, Duijm LE, Tjan-Heijnen VC, Voogd AC.

Ann Surg Oncol. 2015 May;22(5):1471-8. doi: 10.1245/s10434-014-4175-7. Epub 2014 Oct 17.

PMID:
25323475
8.

Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.

Li P, Liu T, Wang Y, Shao S, Zhang W, Lv Y, Yi J, Wang Z.

Clin Breast Cancer. 2013 Feb;13(1):53-60. doi: 10.1016/j.clbc.2012.09.011. Epub 2012 Oct 26.

PMID:
23103368
9.

Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.

Arps DP, Jorns JM, Zhao L, Bensenhaver J, Kleer CG, Pang JC.

Ann Surg Oncol. 2014 Dec;21(13):4152-8. doi: 10.1245/s10434-014-3871-7. Epub 2014 Jul 1.

PMID:
24980090
10.

MRI staging after neoadjuvant chemotherapy for breast cancer: does tumor biology affect accuracy?

McGuire KP, Toro-Burguete J, Dang H, Young J, Soran A, Zuley M, Bhargava R, Bonaventura M, Johnson R, Ahrendt G.

Ann Surg Oncol. 2011 Oct;18(11):3149-54. doi: 10.1245/s10434-011-1912-z. Epub 2011 Sep 27.

PMID:
21947592
11.

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.

Wenzel C, Bartsch R, Hussian D, Pluschnig U, Altorjai G, Zielinski CC, Lang A, Haid A, Jakesz R, Gnant M, Steger GG.

Breast Cancer Res Treat. 2007 Jul;104(1):109-14. Epub 2006 Oct 24.

PMID:
17061042
12.

[Comparison of histopathologic changes and expression of biomarkers in breast carcinoma before and after neoadjuvant chemotherapy].

Zheng S, Zhang BL, Xiao T, Zou SM, Xue LY, Luo W, Guo L, Liu XY, Lü N.

Zhonghua Bing Li Xue Za Zhi. 2011 Jul;40(7):465-70. Chinese.

PMID:
22088373
13.

Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.

Sharma SD, Barry M, O'Reilly EA, Kell MR.

Eur J Surg Oncol. 2015 Jan;41(1):79-85. doi: 10.1016/j.ejso.2014.09.004. Epub 2014 Oct 2.

PMID:
25441933
14.

The poor responsiveness of infiltrating lobular breast carcinomas to neoadjuvant chemotherapy can be explained by their biological profile.

Mathieu MC, Rouzier R, Llombart-Cussac A, Sideris L, Koscielny S, Travagli JP, Contesso G, Delaloge S, Spielmann M.

Eur J Cancer. 2004 Feb;40(3):342-51.

PMID:
14746851
15.

The relevance of breast cancer subtypes in the outcome of neoadjuvant chemotherapy.

Straver ME, Rutgers EJ, Rodenhuis S, Linn SC, Loo CE, Wesseling J, Russell NS, Oldenburg HS, Antonini N, Vrancken Peeters MT.

Ann Surg Oncol. 2010 Sep;17(9):2411-8. doi: 10.1245/s10434-010-1008-1. Epub 2010 Apr 6.

16.

Pathologic complete response after neoadjuvant chemotherapy in HER2-overexpressing breast cancer according to hormonal receptor status.

Tanioka M, Sasaki M, Shimomura A, Fujishima M, Doi M, Matsuura K, Sakuma T, Yoshimura K, Saeki T, Ohara M, Tsurutani J, Watatani M, Takano T, Kawabata H, Mukai H, Naito Y, Hirokaga K, Takao S, Minami H.

Breast. 2014 Aug;23(4):466-72. doi: 10.1016/j.breast.2014.03.008. Epub 2014 Apr 16.

PMID:
24742606
17.
18.

Comparison of the clinicopathological features of invasive ductal, invasive lobular, and mixed (invasive ductal + invasive lobular) carcinoma of the breast.

Zengel B, Yararbas U, Duran A, Uslu A, Elıyatkın N, Demırkıran MA, Cengiz F, Şimşek C, Postacı H, Vardar E, Durusoy R.

Breast Cancer. 2015 Jul;22(4):374-81. doi: 10.1007/s12282-013-0489-8. Epub 2013 Aug 8.

PMID:
23925582
19.

Clinical outcomes using accelerated partial breast irradiation in patients with invasive lobular carcinoma.

Shah C, Wilkinson JB, Shaitelman S, Grills I, Wallace M, Mitchell C, Vicini F.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e547-51. doi: 10.1016/j.ijrobp.2011.04.050. Epub 2011 Jun 2.

PMID:
21640491
20.

Comparative Long-term Study of a Large Series of Patients with Invasive Ductal Carcinoma and Invasive Lobular Carcinoma. Loco-Regional Recurrence, Metastasis, and Survival.

García-Fernández A, Lain JM, Chabrera C, García Font M, Fraile M, Barco I, Torras M, Reñe A, González S, González C, Piqueras M, Veloso E, Cirera L, Pessarrodona A, Giménez N.

Breast J. 2015 Sep-Oct;21(5):533-7. doi: 10.1111/tbj.12455. Epub 2015 Jul 17.

PMID:
26190560

Supplemental Content

Support Center